{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:41:41Z","timestamp":1793374901316,"version":"4.5.0"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/mot.0b013e3283636c20","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T13:50:48Z","timestamp":1373377848000},"page":"445-454","source":"Crossref","is-referenced-by-count":42,"title":["Kidney transplantation across HLA and ABO antibody barriers"],"prefix":"10.1097","volume":"18","author":[{"given":"Luis E.","family":"Becker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caner","family":"S\u00fcsal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Morath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20211004","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1172\/JCI103085","article-title":"Experiences with renal homotransplantation in the human: report of nine cases.","volume":"34","author":"Hume","year":"1955","journal-title":"J Clin Invest"},{"key":"R2-11-20211004","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation.","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"key":"R3-11-20211004","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/TP.0b013e3181b04a5f","article-title":"Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program.","volume":"88","author":"Claas","year":"2009","journal-title":"Transplantation"},{"key":"R4-11-20211004","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1432-2277.2012.01526.x","article-title":"Persistently low transplantation rate of ABO blood type O and highly sensitised patients despite alternative transplantation programs.","volume":"25","author":"Roodnat","year":"2012","journal-title":"Transpl Int"},{"key":"R5-11-20211004","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/TP.0b013e3181c90270","article-title":"Impact of the 1998 UK National Allocation Scheme for deceased heartbeating donor kidneys.","volume":"89","author":"Fuggle","year":"2010","journal-title":"Transplantation"},{"key":"R6-11-20211004","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"R7-11-20211004","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/TP.0b013e31819f2024","article-title":"ABO incompatible renal transplantation: a paradigm ready for broad implementation.","volume":"87","author":"Montgomery","year":"2009","journal-title":"Transplantation"},{"key":"R8-11-20211004","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/TP.0b013e31820f08e8","article-title":"The 5-year outcome of ABO-incompatible kidney transplantation with rituximab induction.","volume":"91","author":"Fuchinoue","year":"2011","journal-title":"Transplantation"},{"key":"R9-11-20211004","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/TP.0b013e31824836ae","article-title":"ABO-incompatible kidney transplantation enabled by nonantigen-specific immunoadsorption.","volume":"93","author":"Morath","year":"2012","journal-title":"Transplantation"},{"key":"R10-11-20211004","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/TP.0b013e3182802f88","article-title":"Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximab.","volume":"95","author":"Vo","year":"2013","journal-title":"Transplantation"},{"key":"R11-11-20211004","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1093\/ndt\/gfq229","article-title":"Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis.","volume":"25","author":"Wilpert","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R12-11-20211004","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/ndt\/gfr237","article-title":"The efficacy of antigen-specific immunoadsorption and rebound of anti-AB antibodies in ABO-incompatible kidney transplantation.","volume":"26","author":"Genberg","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R13-11-20211004","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1600-6143.2011.03464.x","article-title":"Successful ABO-incompatible kidney transplantation with antibody removal and standard immunosuppression.","volume":"11","author":"Flint","year":"2011","journal-title":"Am J Transplant"},{"key":"R14-11-20211004","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1600-6143.2011.03830.x","article-title":"Chronic antibody-mediated rejection is reduced by targeting B-cell immunity during an introductory period.","volume":"12","author":"Kohei","year":"2012","journal-title":"Am J Transplant"},{"key":"R15-11-20211004","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/TP.0b013e318245b2af","article-title":"Outcomes of ABO-incompatible kidney transplantation in the United States.","volume":"93","author":"Montgomery","year":"2012","journal-title":"Transplantation"},{"key":"R16-11-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trre.2012.07.003","article-title":"ABO-incompatible kidney transplantation.","volume":"27","author":"Takahashi","year":"2013","journal-title":"Transplant Rev (Orlando)"},{"key":"R17-11-20211004","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1600-6143.2008.02524.x","article-title":"Positive cross-match living donor kidney transplantation: longer-term outcomes.","volume":"9","author":"Haririan","year":"2009","journal-title":"Am J Transplant"},{"key":"R18-11-20211004","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-6143.2012.04291.x","article-title":"Five-year outcomes in living donor kidney transplants with a positive crossmatch.","volume":"13","author":"Bentall","year":"2013","journal-title":"Am J Transplant"},{"key":"R19-11-20211004","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival.","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"key":"R20-11-20211004","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1432-2277.2012.01490.x","article-title":"Prevention of antibody-mediated kidney transplant rejection.","volume":"25","author":"Morath","year":"2012","journal-title":"Transpl Int"},{"key":"R21-11-20211004","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/TP.0b013e3181ea3985","article-title":"An integrative approach for the transplantation of high-risk sensitized patients.","volume":"90","author":"Morath","year":"2010","journal-title":"Transplantation"},{"key":"R22-11-20211004","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1600-6143.2006.01356.x","article-title":"C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings.","volume":"6","author":"Haas","year":"2006","journal-title":"Am J Transplant"},{"key":"R23-11-20211004","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.bbrc.2009.12.042","article-title":"Significance of HLA class I antibody-induced antioxidant gene expression for endothelial cell protection against complement attack.","volume":"391","author":"Iwasaki","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"R24-11-20211004","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1111\/j.1600-6143.2011.03646.x","article-title":"Complement inhibition enables renal allograft accommodation and long-term engraftment in presensitized nonhuman primates.","volume":"11","author":"Chen Song","year":"2011","journal-title":"Am J Transplant"},{"key":"R25-11-20211004","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/TP.0b013e3182424df3","article-title":"Comparative study on signal transduction in endothelial cells after antiab and human leukocyte antigen antibody reaction: implication of accommodation.","volume":"93","author":"Iwasaki","year":"2012","journal-title":"Transplantation"},{"key":"R26-11-20211004","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.atherosclerosissup.2012.10.030","article-title":"Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis.","volume":"14","author":"Klein","year":"2013","journal-title":"Atheroscler Suppl"},{"key":"R27-11-20211004","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1111\/j.1600-6143.2010.03226.x","article-title":"Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation.","volume":"10","author":"Bartel","year":"2010","journal-title":"Am J Transplant"},{"key":"R28-11-20211004","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1432-2277.2012.01447.x","article-title":"Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy.","volume":"25","author":"Morath","year":"2012","journal-title":"Transpl Int"},{"key":"R29-11-20211004","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/TP.0b013e3181919a16","article-title":"Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.","volume":"87","author":"Thielke","year":"2009","journal-title":"Transplantation"},{"key":"R30-11-20211004","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients.","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"R31-11-20211004","first-page":"738","article-title":"Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987; 19:4538-4542.","volume":"94","author":"Alexandre","year":"2012","journal-title":"Transplantation"},{"key":"R32-11-20211004","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-6143.2004.00653.x","article-title":"ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab.","volume":"5","author":"Tyden","year":"2005","journal-title":"Am J Transplant"},{"key":"R33-11-20211004","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/TP.0b013e31823bb689","article-title":"Desensitization with antigen-specific immunoadsorption interferes with complement in ABO-incompatible kidney transplantation.","volume":"93","author":"Biglarnia","year":"2012","journal-title":"Transplantation"},{"key":"R34-11-20211004","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/ndt\/gfr610","article-title":"Anti-AB antibody depletion by semiselective versus ABO blood group-specific immunoadsorption.","volume":"27","author":"Wahrmann","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R35-11-20211004","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.","volume":"15","author":"Jordan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R36-11-20211004","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/TP.0b013e318253f7b6","article-title":"Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients.","volume":"94","author":"Alachkar","year":"2012","journal-title":"Transplantation"},{"key":"R37-11-20211004","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/TP.0b013e3182590d2e","article-title":"Lack of effect in desensitization with intravenous immunoglobulin and rituximab in highly sensitized patients.","volume":"94","author":"Marfo","year":"2012","journal-title":"Transplantation"},{"key":"R38-11-20211004","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/TP.0b013e3181daaaf1","article-title":"Polyomavirus BK neutralizing activity in human immunoglobulin preparations.","volume":"89","author":"Randhawa","year":"2010","journal-title":"Transplantation"},{"key":"R39-11-20211004","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2215\/CJN.00770112","article-title":"Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients.","volume":"7","author":"Sharif","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R40-11-20211004","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00007890-198405000-00009","article-title":"The late adverse effect of splenectomy on patient survival following cadaveric renal transplantation.","volume":"37","author":"Alexander","year":"1984","journal-title":"Transplantation"},{"key":"R41-11-20211004","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s11255-012-0231-z","article-title":"ABO-incompatible kidney transplantation in elderly patients over 60 years of age.","volume":"44","author":"Uchida","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"R42-11-20211004","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1600-6143.2006.01709.x","article-title":"The Utility of splenectomy as rescue treatment for severe acute antibody mediated rejection.","volume":"7","author":"Locke","year":"2007","journal-title":"Am J Transplant"},{"key":"R43-11-20211004","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-6143.2008.02461.x","article-title":"Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production.","volume":"9","author":"Perry","year":"2009","journal-title":"Am J Transplant"},{"key":"R44-11-20211004","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/TP.0b013e318190af83","article-title":"Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.","volume":"86","author":"Everly","year":"2008","journal-title":"Transplantation"},{"key":"R45-11-20211004","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/TP.0b013e3181c6ff8d","article-title":"Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection.","volume":"89","author":"Walsh","year":"2010","journal-title":"Transplantation"},{"key":"R46-11-20211004","first-page":"493","article-title":"Bortezomib does not reduce ABO-isoagglutinin titers and may not be useful for ABO-incompatible transplant desensitization.","volume":"491-","author":"Boothpur","year":"2009","journal-title":"Clin Transpl"},{"key":"R47-11-20211004","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/TP.0b013e3181d9e1c0","article-title":"Effect of the proteasome inhibitor bortezomib on humoral immunity in two presensitized renal transplant candidates.","volume":"89","author":"Wahrmann","year":"2010","journal-title":"Transplantation"},{"key":"R48-11-20211004","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.trim.2012.01.002","article-title":"Proteasome inhibition by bortezomib: effect on HLA-antibody levels and specificity in sensitized patients awaiting renal allograft transplantation.","volume":"26","author":"Guthoff","year":"2012","journal-title":"Transpl Immunol"},{"key":"R49-11-20211004","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/eji.200737743","article-title":"Dampening Ab responses using proteasome inhibitors following in vivo B cell activation.","volume":"38","author":"Cascio","year":"2008","journal-title":"Eur J Immunol"},{"key":"R50-11-20211004","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.transproceed.2012.09.038","article-title":"Eculizumab treatment of acute antibody-mediated rejection in renal transplantation: case reports.","volume":"44","author":"Gonzalez-Roncero","year":"2012","journal-title":"Transplant Proc"},{"key":"R51-11-20211004","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1111\/j.1600-6143.2012.04124.x","article-title":"Antibody mediated rejection associated with complement factor h-related protein 31 deficiency successfully treated with eculizumab.","volume":"12","author":"Noone","year":"2012","journal-title":"Am J Transplant"},{"key":"R52-11-20211004","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.transproceed.2012.03.053","article-title":"Case report: Eculizumab rescue of severe accelerated antibody-mediated rejection after ABO-incompatible kidney transplant.","volume":"44","author":"Stewart","year":"2012","journal-title":"Transplant Proc"},{"key":"R58-11-20211004","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/TP.0b013e3182612967","article-title":"High transplant rates of highly sensitized recipients with virtual crossmatching in kidney paired donation.","volume":"94","author":"Ferrari","year":"2012","journal-title":"Transplantation"},{"key":"R60-11-20211004","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1600-6143.2010.03034.x","article-title":"Altruistic donor triggered domino-paired kidney donation for unsuccessful couples from the kidney-exchange program.","volume":"10","author":"Roodnat","year":"2010","journal-title":"Am J Transplant"},{"key":"R61-11-20211004","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/TP.0b013e3181804a34","article-title":"Exchange living-donor kidney transplantation: merits and limitations.","volume":"86","author":"Huh","year":"2008","journal-title":"Transplantation"},{"key":"R62-11-20211004","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa0803645","article-title":"A nonsimultaneous, extended, altruistic-donor chain.","volume":"360","author":"Rees","year":"2009","journal-title":"N Engl J Med"}],"container-title":["Current Opinion in Organ Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00075200-201308000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T09:40:04Z","timestamp":1633513204000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075200-201308000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mot.0b013e3283636c20","relation":{},"ISSN":["1087-2418"],"issn-type":[{"value":"1087-2418","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}